Document:

ex4_1.htm

Exhibit 4.1

 

 

SECOND AMENDMENT TO RIGHTS AGREEMENT

 

This SECOND AMENDMENT TO RIGHTS AGREEMENT (this “Amendment”), dated as of April 9, 2010, is between Boots & Coots, Inc., a Delaware corporation formerly known as Boots & Coots International Well Control, Inc. (the “Company”), and American Stock Transfer & Trust Company, LLC, as Rights Agent (the “Rights Agent”).  Capitalized terms used but not defined herein have the meanings ascribed to such terms in the Rights Agreement (as defined below).

 

RECITALS

 

WHEREAS, the Company and the Rights Agent are parties to a Rights Agreement, dated as of November 27, 2001, as amended by the First Amendment to Rights Agreement dated November 21, 2005 (the “Rights Agreement”); and

 

WHEREAS, it is proposed that the Company, Halliburton Company, a Delaware corporation (“Parent”), and Gradient, LLC, a Delaware limited liability company (“Merger Sub”), enter into an Agreement and Plan of Merger of even date herewith (the “Merger Agreement”), pursuant to which the Company will merge with and into Merger Sub (the “Merger”); and

 

WHEREAS, pursuant to Section 27 of the Rights Agreement, at any time prior to the Distribution Date, the Company may by action of its Board of Directors, and the Rights Agents shall if the Company so directs, supplement or amend any provision of the Rights Agreement in any manner without the approval of any holder of the Rights; and

 

WHEREAS, the Distribution Date has not occurred; and

 

WHEREAS, the Board of Directors of the Company has determined that it is in the best interests of the Company and its stockholders to amend the Rights Agreement to, among other things, except the Merger Agreement and the transactions contemplated thereby, including the Merger, from the Rights Agreement.

 

NOW, THEREFORE, in consideration of the mutual covenants and agreements contained herein and other good and valuable consideration, and intending to be legally bound hereby, the Company hereby amends the Rights Agreement as follows:

 

 1.       Amendment to Section 1.  Section 1 of the Rights Agreement is amended to add the following at the end thereof:

 

	
  

	
“(z)

	
“Merger” shall mean the merger of the Company and Merger Sub pursuant to the Merger Agreement and the transactions contemplated by the Merger Agreement.

 

	
  

	
(aa)

	
“Merger Agreement” shall mean that certain Agreement and Plan of Merger, dated as of April 9, 2010, by and among the Company, Parent and Merger Sub.

 

	
  

	
(bb)

	
“Merger Sub” shall mean Gradient, LLC, a Delaware limited liability company.

 

  

  

  

	
  

	
(cc)

	
“Parent” shall mean Halliburton Company, a Delaware corporation.”

 

 2.      Amendment to the definition of “Acquiring Person.”  Section 1(b) of the Rights Agreement is amended to add the following sentence at the end thereof:

 

“Notwithstanding anything in this Agreement to the contrary, none of  Parent, Merger Sub or any Subsidiary, Affiliate or Associate of Parent or Merger Sub shall be deemed to be an Acquiring Person, either individually or collectively, as a result of (i) the execution, delivery and performance of the Merger Agreement, (ii) the consummation of the Merger, (iii) the announcement of the Merger Agreement or the Merger or (iv) the consummation of any other transaction contemplated in the Merger Agreement.”

 

 3.      Amendment to the definition of “Distribution Date.” Section 1(j) of the Rights Agreement is amended to add the following sentence at the end thereof: 

 

“Notwithstanding anything in this Agreement to the contrary, a Distribution Date shall not be deemed to have occurred solely as the result of (i) the execution, delivery and performance of the Merger Agreement, (ii) the consummation of the Merger, (iii) the announcement of the Merger Agreement or the Merger or (iv) the consummation of any other transaction contemplated in the Merger Agreement.”

 

 4.      Amendment to the definition of “Stock Acquisition Date.”  Section 1(t) of the Rights Agreement is amended to add the following sentence at the end thereof:

 

“Notwithstanding anything in this Agreement to the contrary, a Stock Acquisition Date shall not be deemed to have occurred solely as the result of (i) the execution, delivery and performance of the Merger Agreement, (ii) the consummation of the Merger, (iii) the announcement of the Merger Agreement or the Merger or (iv) the consummation of any other transaction contemplated in the Merger Agreement.”

 

 5.      Amendment to the definition of “Triggering Event.”  Section 1(w) of the Rights Agreement is amended to add the following at the end thereof:

 

“Notwithstanding anything in this Agreement to the contrary, a Triggering Event shall not occur by reason of (i) the approval, execution, delivery and performance of the Merger Agreement, (ii) the consummation of the Merger, (iii) the announcement of the Merger Agreement or the Merger or (iv) the consummation of any other transaction contemplated in the Merger Agreement.”

 

 6.      Amendment to Section 3.  Section 3 of the Rights Agreement is amended to add the following sentence at the end thereof as Section 3(d):

 

“(d)           Nothing in this Agreement shall be construed to give any holder of Rights or any other Person any legal or equitable rights, remedies or claims under this Agreement by virtue of the execution of the Merger Agreement or by virtue of the Merger or any of the other transactions contemplated by the Merger Agreement, including without limitation the consummation thereof.”

 

  

2

  

 7.      Amendment to Section 11(a)(ii).  Section 11(a)(ii) of the Rights Agreement is amended to add the following sentence at the end thereof:

 

“Notwithstanding anything in this Agreement to the contrary, an event requiring an adjustment under this Section 11(a)(ii) shall not be deemed to have occurred solely as the result of (i) the execution, delivery and performance of the Merger Agreement, (ii) the consummation of the Merger, (iii) the announcement of the Merger Agreement or the Merger or (iv) the consummation of any other transaction contemplated in the Merger Agreement.”

 

 8.      Amendment to Section 13.  Section 13 of the Rights Agreement is amended to add the following sentence at the end thereof as Section 13(f):

 

“(f)           The provisions of this Section 13 shall not apply to (i) the execution, delivery and performance of the Merger Agreement, (ii) the consummation of the Merger, (iii) the announcement of the Merger Agreement or the Merger or (iv) the consummation of any other transaction contemplated in the Merger Agreement.”

 

 9.      Effectiveness.  This Amendment shall be deemed effective as of the date first written above.  Except as amended hereby, the Rights Agreement shall remain in full force and effect and shall be otherwise unaffected hereby.

 

 10.    Severability.  If any term, provision, covenant or restriction of this Amendment is held by a court of competent jurisdiction or other authority to be invalid, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions of this Amendment shall remain in full force and effect and shall in no way be affected, impaired or invalidated. 

 

 11.    Termination of Plan. If for any reason the Merger Agreement is terminated and the transactions contemplated thereby are abandoned, this Amendment shall be of no further force and effect and the Rights Agreement shall remain the same as it existed immediately prior to the execution of this Amendment.

 

 12.    Governing Law.  This Amendment shall be deemed to be a contract made under the laws of the State of New York and for all purposes shall be governed by and construed in accordance with the laws of such state applicable to contracts made and to be performed entirely within such state.

 

 13.    Counterparts.  This Amendment may be executed in any number of counterparts, each of such counterparts shall for all purposes be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument.

 

[SIGNATURE PAGE FOLLOWS]

 

  

3

  

IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed by their respective authorized officers, as of the day and year first above written.

 

	  	
BOOTS & COOTS, INC.

	  	  	  
	  	  	  
	  	  	  
	  	
By:

	
/s/ Jerry Winchester

	  	
Name: 

	
Jerry Winchester

	  	
Title:

	
President & CEO

	  	  	  
	  	  	  
	  	
AMERICAN STOCK TRANSFER & TRUST COMPANY, LLC

	  	  	  
	  	  	  
	  	  	  
	  	
By:

	
/s/ Felix Orihuela

	  	
Name:

	
Felix Orihuela

	  	
Title:

	
Vice President

 

 

[SIGNATURE PAGE TO SECOND AMENDMENT TO RIGHTS AGREEMENT]Unassociated Document

    SETTLEMENT
AGREEMENT

     

    THIS SETTLEMENT AGREEMENT
(this “Agreement”) is made
by and between NuRx Pharmaceuticals, Inc. (“NuRx”), a corporation
existing under the laws of Nevada, and DYVA Holding Ltd. (“DYVA”), a corporation
existing under the laws of Switzerland.  NuRx and DYVA are sometimes
individually referred to herein as a “Party” and
collectively as the “Parties.”

     

    W I T N E
S S E T H:

     

    WHEREAS,
NuRx and DYVA are parties to a lawsuit titled “DYVA Holding Ltd. v. NuRx
Pharmaceuticals, Inc.,” Case No. 2:09-cv-2178-KJD-LRL, pending in the United
States District Court, District of Nevada (the “Lawsuit”);
and

     

    WHEREAS,
NuRx and DYVA are desirous of settling and resolving the Lawsuit on the terms
and conditions set forth in this Agreement.

     

    NOW
THEREFORE, in consideration of the mutual covenants and conditions set forth
herein, NuRx and DYVA agree as follows:

     

    SECTION
1

     

    Representations
and Warranties

     

    1.1           Authorization;
Enforceability.  Each Party represents and warrants to the
other Party that such Party has all requisite power and authority or capacity to
execute, deliver and perform its obligations under this Agreement and any other
document to be executed and delivered by it pursuant hereto.  The
execution, delivery and performance by such Party of this Agreement and any
other document to be executed and delivered by it pursuant hereto, and the
consummation by such Party of the transactions contemplated by this Agreement,
have been duly authorized by all necessary corporate or other action of such
Party and no other action on the part of such Party is necessary to authorize
this Agreement or the transactions contemplated by this
Agreement.  This Agreement and any other document to be executed and
delivered by such Party pursuant hereto have been duly executed and delivered by
such Party and constitute valid and binding obligations of such Party,
enforceable against such Party in accordance with their respective
terms.

     

    1.2           Absence of
Conflict.  Each Party represents and warrants to the other
Party that neither the execution and delivery by such Party of this Agreement,
nor the consummation by such Party of the transactions contemplated by this
Agreement: (i) violates, is in conflict with, accelerates the performance
required by or constitutes a default (or an event which, with notice or lapse of
time or both, would constitute a default) under any material agreement or
commitment to which such Party is a party or by which any of such Party’s
properties or assets is bound, (ii) violates any statute or law or any judgment,
decree, order, regulation or rule of any court or other governmental authority
applicable to such Party, or (iii) conflicts with or violates any provision of
such Party’s charter, bylaws or any equivalent organizational or governing
documents.

     

    
      
         

      

      
        SETTLEMENT
AGREEMENT, Page 1 of 6

        
          

        

      

      
         

      

    

     

    SECTION
2

     

    Payment

     

    NuRx
shall pay to DYVA, in care of the Trust Account at the law firm of Brownstein
Hyatt Farber Schreck, LLP (“BHFS”), the sum of
FOUR HUNDRED THOUSAND AND NO/100 DOLLARS ($400,000.00) to BHFS on or before
12:00 PM on April 8, 2010.

     

    SECTION
3

     

    Mutual
Release

     

    3.1           Except
for the obligations set forth in this Settlement Agreement, NuRx hereby forever
releases and discharges DYVA and its past and present subsidiary corporations,
parent corporations, affiliates, partners, members, joint venturers, heirs,
successors, assigns, officers, directors, shareholders, employees, agents,
attorneys and insurers (in their individual and representative capacities) from
any and all claims, demands, losses, damages, actions, causes of action, suits,
debts, promises, liabilities, obligations, liens, costs, expenses, attorneys’
fees, indemnities, subrogations (contractual or equitable) or duties, of any
nature, character or description whatsoever, whether known or unknown, fixed or
contingent, accrued or not yet accrued, matured or not yet matured, anticipated
or unanticipated, asserted or unasserted, arising from or related to, directly
or indirectly, the Lawsuit.

     

    3.2           Except
for the obligations set forth in this Settlement Agreement, and upon the receipt
of all of the consideration specified in Section 2, DYVA
forever releases and discharges NuRx and its past and present subsidiary
corporations, parent corporations, affiliates, partners, members, joint
venturers, heirs, successors, assigns, officers, directors, shareholders,
employees, agents, attorneys and insurers (in their individual and
representative capacities) from any and all claims, demands, losses, damages,
actions, causes of action, suits, debts, promises, liabilities, obligations,
liens, costs, expenses, attorneys’ fees, indemnities, subrogations (contractual
or equitable) or duties, of any nature, character or description whatsoever,
whether known or unknown, fixed or contingent, accrued or not yet accrued,
matured or not yet matured, anticipated or unanticipated, asserted or
unasserted, arising from or related to, directly or indirectly, the
Lawsuit.

     

    SECTION
4

     

    Dismissal
of the Lawsuit

     

    Upon
NuRx’s satisfaction of all obligations in Sections 2, 5 and 6, the Lawsuit shall
be dismissed with prejudice by the filing of a Stipulation and Order for
Dismissal with Prejudice, attached to this Agreement as Exhibit
A.

     

    
      
         

      

      
        SETTLEMENT
AGREEMENT, Page 2 of 6

        
          

        

      

      
         

      

    

     

    SECTION
5

     

    Amendment
to Rights Agreement

     

    Upon
execution of this Settlement Agreement, NuRx shall provide satisfactory proof
that it has amended the Stockholder Rights Agreement, dated June 1, 2009, by and
between NuRx and Continental Stock Transfer & Trust Company as Rights
Agent (“CST”),
as amended by the Amendment to Stockholder Rights Agreement, dated January 27,
2010, by and between NuRx and CST (as amended, the “Rights Agreement”)
such that the definition of “Exempt Person” in Section 1 of the Rights
Agreement shall be amended and restated to read in its entirety as
follows:

     

    “Exempt Person”
means

     

    (i)         the
Company, any Subsidiary of the Company, any employee benefit plan or employee
stock plan of the Company or of any Subsidiary of the Company, or any person or
entity organized, appointed, established or holding Company Common Stock for or
pursuant to the terms of any such plan;

     

    (ii)         any
Person who would otherwise become an Acquiring Person solely by virtue of a
reduction in the number of outstanding shares of Company Common Stock; provided, however, that any such Person
shall not be an Exempt Person if, subsequent to such reduction, such Person
shall become the Beneficial Owner of any additional shares of Company Common
Stock;

     

    (iii)                   Dr.
Parkash Gill and his immediate family members and their Affiliates and
Associates, provided,
however, that any such
Person shall not be an Exempt Person if such Person shall become the Beneficial
Owner of any additional shares of Company Common Stock after the effective time
of this Agreement;

     

    (iv)                   Parent
and Merger Sub (each as defined in the Merger Agreement), either individually or
together, solely in connection with the approval, execution and delivery of the
Merger Agreement and the Voting Agreements, and any of the transactions
contemplated thereby, including, but not limited to, the Merger (as defined in
the Merger Agreement); or

     

    (v)         DYVA
Holding Ltd. and its Affiliates and their respective Associates; provided, however, that no such person
shall be an Exempt Person if DYVA Holding Ltd. shall become the Beneficial
Owner, either directly or beneficially, of any additional shares of Company
Common Stock acquired during the period beginning April 9, 2010 and ending April
9, 2012.”

     

    
      
         

      

      
        SETTLEMENT
AGREEMENT, Page 3 of 6

        
          

        

      

      
         

      

    

     

    SECTION
6

     

    Redemption
Plan

     

    At the
time of execution of this Settlement Agreement, NuRx shall provide satisfactory
proof that it has withdrawn its claimed redemption rights over any of DYVA’s
shares, whether directly or beneficially owned.  NuRx further
represents and warrants that its redemption By Law adopted on September 22,
2009, is inapplicable to all of DYVA’s shares, as those shares were acquired
prior to the redemption By Law’s existence.

     

    SECTION
7

     

    Voting
Agreement

     

    DYVA
shall execute and deliver to NuRx the voting agreement in substantially the form
attached hereto as Exhibit
B.

     

    SECTION
8

     

    Binding
Effect

     

    This
Agreement shall inure to the benefit of and be binding upon the Parties and
their respective heirs, successors and assigns.

     

    SECTION
9

     

    Time
of the Essence

     

    Time is
of the essence of this Agreement and all of its terms, provisions, conditions
and covenants.

     

    SECTION
10

     

    Entire
Agreement

     

    This
Agreement contains the entire agreement between the Parties and may not be
changed or terminated orally but only by a written instrument executed by the
Parties after the date of this Agreement.

     

    SECTION
11

     

    Construction

     

    The terms
and conditions of this Agreement shall be construed as a whole according to its
fair meaning and not strictly for or against any Party.  The Parties
acknowledge that each of them has reviewed this Agreement and has had the
opportunity to have it reviewed by their  respective attorneys and
that any rule of construction to the effect that ambiguities are to be resolved
against the drafting party shall not apply in the interpretation of this
Agreement.

     

    
      
         

      

      
        SETTLEMENT
AGREEMENT, Page 4 of 6

        
          

        

      

      
         

      

    

     

    SECTION
12

     

    Attorneys’
Fees

     

    In any
action or proceeding to enforce the terms of this Agreement or to redress any
violation of this Agreement, the prevailing party shall be entitled to recover
as damages its attorneys’ fees and costs incurred, whether or not the action is
reduced to judgment.  For the purposes of this provision, the
“prevailing party” shall be that party who has been successful with regard to
the main issue, even if that party did not prevail on all issues.

     

    SECTION
13

     

    Governing
Law and Forum

     

    The laws
of the State of Nevada (without giving effect to choice of law or conflict of
law principles) shall govern this Agreement, including the validity,
construction, performance and effect thereof.  Any lawsuit, action or
proceeding to interpret or enforce the terms of this Agreement shall be brought
in a court of competent jurisdiction in the County of Clark, State of
Nevada.

     

    SECTION
14

     

    Necessary
Action

     

    Each of
the Parties shall do any act or thing and execute any and all documents or
instruments necessary or proper to effectuate the provisions and intent of this
Agreement.

     

    SECTION
15

     

    Counterparts

     

    This
Agreement may be executed in any number of counterparts, each of which when duly
executed and delivered shall be deemed an original, but all such counterparts
shall constitute one and the same agreement.  Any signature page of
this Agreement may be detached from any counterpart without impairing the legal
effect of any signatures, and may be attached to another counterpart, identical
in form, but having attached to it one or more additional signature
pages.  This Agreement may be executed by signatures provided by
electronic facsimile transmission (also known as “Fax” copies), which facsimile
signatures shall be as binding and effective as original
signatures.

     

    SECTION
16

     

    Effective
Date of Agreement

     

    The
effective date of this Agreement shall be the date on which the last Party who
is to sign this Agreement signs the Agreement.

     

    
      
         

      

      
        SETTLEMENT
AGREEMENT, Page 5 of 6

        
          

        

      

      
         

      

    

     

    SECTION
17

     

    Authority
to Execute

     

    Each
Party represents, covenants and warrants to the other that it has all the
necessary and required power and authority to enter into this Agreement, and
that each individual executing this Agreement on behalf of any Party
specifically warrants that he or she has the authority to bind that entity by
his or her signature.

     

    
      
        
          
            
              
                
                  
                    
                      	 	      
                              “DYVA”

                            	 	 	      
                              “NuRx”

                            	 
	 	 	 	 	 	 
	 	      
                              Executed
      this 9th day of April 2010

                            	 	 	      
                              Executed
      this 9th day of April 2010

                            	 
	 	 	 	 	 	 
	 	      
                              DYVA
      HOLDING LTD.

                            	 	 	      
                              NURX
      PHARMACEUTICALS, INC.

                            	 
	 	 	 	 	 	 
	By: 	
                              /s/
      Paul Bagley

                            	 	By:	
                              /s/
      Harin Padma-Nathan

                            	 
	 	
                                    
                                Name: Paul
      Bagley

                              

                            	 	 	
                                    
                                Name:  Harin
      Padma-Nathan

                              

                            	 
	 	
                                    
                                Title:Attorney-in-Fact

                              

                            	 	 	
                                    
                                Title:Chief
      Executive Officer

                              

                            	 

                    

                  

                

              

            

          

        

      

    

     

    
       

    

    
SETTLEMENT
AGREEMENT, Page 6 of 6

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00172-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00172-of-00352.parquet"}]]